Validation of a multivariate model predicting presence and size of varices

被引:49
作者
Burton, James R., Jr.
Liangpunsakul, Suthat
Lapidus, Jodi
Giannini, Edoardo
Chalasani, Naga
Zaman, Atif
机构
[1] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol & Hepatol, Denver, CO 80262 USA
[2] Indiana Univ, Div Gastroenterol & Hepatol, Indianapolis, IN USA
[3] Univ Genoa, Div Gastroenterol & Hepatol, Genoa, Italy
关键词
varices; screening; cirrhosis; LARGE ESOPHAGEAL-VARICES; PORTAL-HYPERTENSION; PRIMARY PROPHYLAXIS; CONSENSUS WORKSHOP; CIRRHOSIS; DIAGNOSIS; METHODOLOGY; STRATEGIES;
D O I
10.1097/01.mcg.0000225669.84099.04
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: A model developed by our group identified low platelets and advanced Child-Pugh class (CPC) as being associated with large varices. Goals: To validate a defined cut-off of platelets <= 80,000/mu L in CPC-A for large varices and platelets <= 90,000/mu L in CPC-B/C for any varices. Study: Validation cohorts consisted of patients with cirrhosis undergoing screening for varices from Oregon Health and Science University (n = 152), Indiana University (n = 252), and Genoa, Italy (n = 101). Similar clinical and laboratory data were collected as for the original cohort. To assess the ability of these cut-offs to predict presence of large and any varices, sensitivity, specificity, positive and negative predictive values, likelihood ratios, and the c-statistic were measured. Results: The validation cohorts were statistically different from the original cohort with regards to CPC and prevalence of large varices. Combining the original (n = 301) and validation cohorts resulted in a negative predictive value of 92.1% for platelets <= 80,000/mu L in CPC-A for large varices and positive predictive value of 80.1% for platelets <= 90,000/mu L in CPC-B/C for any varices. Combining the 4 cohorts yielded a c-statistic of 0.67 (95% confidence interval: 063-0.72). No other factors such as splenomegaly and Model for End-Stage Liver Disease score were identified as significant. Conclusions: This study confirms the validity of a previous model identifying low platelets and advanced CPC class as predictors of large varices. Despite combining the cohorts, no other risk factors were identified.
引用
收藏
页码:609 / 615
页数:7
相关论文
共 20 条
[1]  
Arguedas MR, 2002, AM J GASTROENTEROL, V97, P2441
[2]   INCIDENCE OF LARGE ESOPHAGEAL-VARICES IN PATIENTS WITH CIRRHOSIS - APPLICATION TO PROPHYLAXIS OF 1ST BLEEDING [J].
CALES, P ;
DESMORAT, H ;
VINEL, JP ;
CAUCANAS, JP ;
RAVAUD, A ;
GERIN, P ;
BROUET, P ;
PASCAL, JP .
GUT, 1990, 31 (11) :1298-1302
[3]  
Chalasani N, 1999, AM J GASTROENTEROL, V94, P3285
[4]   THE TREATMENT OF PORTAL-HYPERTENSION - A METAANALYTIC REVIEW [J].
DAMICO, G ;
PAGLIARO, L ;
BOSCH, J .
HEPATOLOGY, 1995, 22 (01) :332-354
[5]   Projecting future complications of chronic hepatitis C in the United States [J].
Davis, GL ;
Albright, JE ;
Cook, SF ;
Rosenberg, DM .
LIVER TRANSPLANTATION, 2003, 9 (04) :331-338
[6]  
de Franchis R, 2000, J HEPATOL, V33, P846
[7]   Evolving consensus in portal hypertension - Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension [J].
de Franchis, R .
JOURNAL OF HEPATOLOGY, 2005, 43 (01) :167-176
[8]   Application of the platelet count/spleen diameter ratio to rule out the presence of oesophageal varices in patients with cirrhosis: A validation study based on follow-up [J].
Giannini, EG ;
Botta, F ;
Borro, P ;
Dulbecco, P ;
Testa, E ;
Mansi, C ;
Savarino, V ;
Testa, R .
DIGESTIVE AND LIVER DISEASE, 2005, 37 (10) :779-785
[9]  
Grace ND, 1997, AM J GASTROENTEROL, V92, P1081
[10]   Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis [J].
Groszmann, RJ ;
Garcia-Tsao, G ;
Bosch, J ;
Grace, ND ;
Burroughs, AK ;
Planas, R ;
Escorsell, A ;
Garcia-Pagan, JC ;
Patch, D ;
Matloff, DS ;
Gao, H ;
Makuch, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (21) :2254-2261